| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pharmacology, University of Padova, 35131 Padova, Italy; and
* Department of Neuroscience Research, SmithKline Beecham Pharmaceuticals, Harlow, Essex CM19 5AW, U.K.
1Correspondence: Department of Pharmacology, L.go Meneghetti, 2, 35131 Padova, Italy. E-mail: giusti{at}ux1.unipd.it
Unilateral injection into the right substantia nigra of the catecholaminergic neurotoxin 6-hydroxydopamine (6-OHDA) produces extensive loss of dopaminergic cells (‘hemi-parkinsonian rat’). The pineal hormone melatonin, which is a potent antioxidant against different reactive oxygen species and has been reported to be neuroprotective in vivo and in vitro, was evaluated for potential anti-Parkinson effects in this model. Imbalance in dopaminergic innervation between the striata produced by intranigral administration of 6-OHDA results in a postural asymmetry causing rotation away from the nonlesioned side. Melatonin given systemically prevented apomorphine-induced circling behavior in 6-OHDA-lesioned rats. Reduced activity of mitochondrial oxidative phosphorylation enzymes has been suggested in some neurodegenerative diseases; in particular, selective decrease in complex I activity is observed in the substantia nigra of Parkinson’s disease patients. Analysis of mitochondrial oxidative phosphorylation enzyme activities in nigral tissue from 6-OHDA-lesioned rats by a novel BN-PAGE histochemical procedure revealed a clear loss of complex I activity, which was protected against in melatonin-treated animals. A good correlation between behavioral parameters and enzymatic (complex I) analysis was observed independent of melatonin administration. A deficit in mitochondrial complex I could conceivably contribute to cell death in parkinsonism via free radical mechanisms, both directly via reactive oxygen species production and by decreased ATP synthesis and energy failure. Melatonin may have potential utility in the treatment of neurodegenerative disorders where oxidative stress is a participant.—Dabbeni-Sala, F., Di Santo, S., Franceschini, D., Skaper, S. D., Giusti, P. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Key Words: Parkinson’s disease • neurodegeneration • pineal hormone • neuroprotection • oxidative phosphorylation
This article has been cited by other articles:
|
|
 |
|
  S. R. Kashyap, A. Lara, R. Zhang, Y. M. Park, and R. A. DeFronzo Insulin Reduces Plasma Arginase Activity in Type 2 Diabetic Patients Diabetes Care, January 1, 2008; 31(1): 134 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Celotto and M. J. Palladino Drosophila: A "Model" Model System To Study Neurodegeneration Mol. Interv., October 1, 2005; 5(5): 292 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Coulom and S. Birman Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster J. Neurosci., December 1, 2004; 24(48): 10993 - 10998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Yadava, T. Houchens, P. Potluri, and I. E. Scheffler Development and Characterization of a Conditional Mitochondrial Complex I Assembly System J. Biol. Chem., March 26, 2004; 279(13): 12406 - 12413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yadava, P. Potluri, E. N. Smith, A. Bisevac, and I. E. Scheffler Species-specific and Mutant MWFE Proteins. THEIR EFFECT ON THE ASSEMBLY OF A FUNCTIONAL MAMMALIAN MITOCHONDRIAL COMPLEX I J. Biol. Chem., June 7, 2002; 277(24): 21221 - 21230. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
